BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy. [electronic resource]
Producer: 20180425Description: 1269-1279 p. digitalISSN:- 1476-5829
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Cyclophosphamide -- therapeutic use
- Dog Diseases -- drug therapy
- Dogs
- Doxorubicin -- therapeutic use
- Female
- Lymph Nodes -- pathology
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Prednisone -- therapeutic use
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Proto-Oncogene Proteins c-myc -- metabolism
- Treatment Outcome
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.